Abstract

The novel 2019 coronavirus disease (COVID-19) with its early origin in China has grown into a globalpandemic.The infection occurs as a mild flu to severe acute respiratory infection and spreads from person toperson through droplet infection.Diagnostic testing has been and will continue to be a big part of the 2019(COVID-19) coronavirus pandemic. Early diagnosis is the key to timely case management and control of thespread of the virus. This article provides a clear understanding of the COVID19 biosafety steps, specimencollection, storage and transportation guidelines.It also addresses steps that can be taken by cytologylaboratories to work during the pandemic and reduce the risk to their employees, trainees and pathologists.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.